In addition to rodents, patients with BWS characterized by IGF-2 overexpression also develop cardiomyopathy characterized by myocardial hypertrophy and myocardial fibrosis as pathological features [85]. This evidence concerns the gene IGF2 and cardiac hypertrophy.